Advaxia Biologics


Advaxia Biologics is a Contract Development & Manufacturing Organization (CDMO), compliant with the regulatory guidelines of the EMA, MHRA and FDA.

Advaxia’s integrated contract services portfolio includes outstanding support in the areas of analytical & process development, GMP Manufacture, full QC product release, ICH Stability and cell banking.

Advaxia is dedicated to the development and production of clinical lots of recombinant adenoviruses to support clinical trials for vaccine and gene therapy applications. The Advaxia team has built an outstanding track record in the production of clinical lots for many infectious diseases, including Ebola, HIV and supported the global effort to expedite delivery of a COVID-19 vaccine.


Get Involved with the Advanced Therapies Congress


To sponsor or exhibit

Ashlea Foster
+44 208 164 3032



To speak

Ila Dickinson
+44 207 092 1150